Aaron Fulgham

An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation.

Birgit Schoeberl, Kwok-Kin Wong, Ulrik B Nielsen, 2010, Cancer research.

Abstract 1690: Mechanistic characterization of MM-131, a bispecific antibody that blocks c-Met signaling through concurrent targeting of EpCAM

Adnan O. Abu-Yousif, B. Schoeberl, U. Nielsen, 2015 .

MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM

B. Schoeberl, U. Nielsen, A. Raue, 2019, Proceedings of the National Academy of Sciences.

Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121)

V. Grantcharova, B. Schoeberl, U. Nielsen, 2017, npj Systems Biology and Applications.

Heteromeric tandem IgG4/IgG1 Fc

B. Schoeberl, U. Nielsen, A. Raue, 2019 .

Crystal structure of EpCAM in complex with scFv

B. Schoeberl, U. Nielsen, A. Raue, 2019 .

Crystal structure of Sema domain of the Met receptor in complex with FAB

B. Schoeberl, U. Nielsen, A. Raue, 2019 .